1.
Murase JE, Munera-Campos M, Hong HC- ho, Taieb A, Chung W-H, Reck Atwater A, Rueda MJ, Zhong J, Buziqui Piruzeli ML, Pau-Charles I, Deleuran M. Lebrikizumab-Treated Patients With Atopic Dermatitis Had No Increase in Treatment-Emergent Adverse Events of Facial, Head, and Neck Erythema Compared to Placebo. J of Skin [Internet]. 2023Nov.13 [cited 2024Sep.20];7(6):s272. Available from: https://dermsquared.com/skin/article/view/2383